Ipsen SA Gross Profit Growth & History (IPN)
Ipsen SA's gross profit was €3.18B for fiscal 2025.
View full Ipsen SA company overviewIpsen SA annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €3.18B | €222.5M | +7.53% |
| 2024 | 2024-12-31 | €2.96B | €220.6M | +8.07% |
| 2023 | 2023-12-31 | €2.74B | €106.5M | +4.05% |
| 2022 | 2022-12-31 | €2.63B | €68.2M | +2.66% |
| 2021 | 2021-12-31 | €2.56B | €364.9M | +16.62% |
| 2020 | 2020-12-31 | €2.20B | — | — |
Ipsen SA gross profit trends
Over the last five fiscal years, Ipsen SA's gross profit increased from €2.20B to €3.18B, a change of €982.7M.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
reported and calculated gross profit
TickerStat uses gross profit reported in company official filings when available. Otherwise, it calculates gross profit as reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ipsen SA source filings ↗Community posts
Ipsen lifts annual growth and margin forecasts after strong drug sales
Ipsen ($IPN) raised its 2026 sales-growth target to approximately 23% at constant exchange rates, from more than 20%, and its core operating-margin forecast to around 39%, from above 37%. Third-quarter revenue reached €1.17 billion, increas ...